ArticleBJR case reports2026
Imaging of Urachal Adenocarcinoma: A Case Report.
Article in BJR case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adenocarcinoma of the urachus is a rare but highly aggressive malignancy that arises from the urachal remnant. Due to its non-specific symptoms and potential to mimic more common and benign conditions, accurate and early diagnosis through imaging is crucial. This report will discuss the role of imaging in urachal adenocarcinoma regarding the characteristics and diagnosis of this tumour, with a focus on CECT, MRI, and ultrasound for detection, staging, and treatment planning. Since urachal adenocarcinoma is a rare and complex disease, optimal results can be achieved only with a combined approach, where close cooperation among urologists, radiologists, oncologists, and pathologists is absolutely necessary. This investigation underlines the importance of increased awareness and expertise in the early and accurate imaging of this malignancy and advocates that optimal survival and quality of life can be best achieved in these patients by a well-coordinated, expert-driven approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.